| Dr Ahmad Bader, MD | |
|
1111 6th Ave Ste B1, Des Moines, IA 50314-2610 | |
| (515) 358-0100 | |
| (515) 358-0109 |
| Full Name | Dr Ahmad Bader |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 19 Years |
| Location | 1111 6th Ave Ste B1, Des Moines, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487037784 | NPI | - | NPPES |
| MD-45592 | Other | IA | IOWA MED. LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MD-45592 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercyone Des Moines Medical Center | Des moines, IA | Hospital |
| St Lukes Hospital | Cedar rapids, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Clinics Inc | 7911810882 | 373 |
News Archive
Humans have 25 different types of functional bitter taste receptors. These are found on our tongue, where they facilitate the taste perception of bitter tasting compounds. In addition, there are increasing findings that cells of extra-oral organs also have such receptors.
Trends indicate that survival is improving in patients with metastatic breast cancer, especially in those patients whose tumours are described as being HER2 (human epidermal growth factor receptor-2) positive, a surgical oncologist will say today (Friday 26 March) at the seventh European Breast Cancer Conference.
Pharmaceuticals, Inc. today announced interim results of a randomized, open‐label, active-control multicenter Phase 2 study of oral ridaforolimus, an investigational mTOR inhibitor, in patients with metastatic or recurrent endometrial cancer. Based on this interim analysis, the study demonstrated a statistically significant improvement in the primary endpoint of median progression-free survival (PFS) in patients receiving single-agent ridaforolimus compared to patients receiving standard-of-care treatment.
Repairing birth defects in the womb. Inserting a tiny laser into the mother's uterus to seal off an abnormal blood flow and save fetal twins. Advancing the science that may allow doctors to deliver cells or DNA to treat sickle cell anemia and other genetic diseases before birth.
A June 2010 independent survey of 408 retirees covered by Medicare revealed that 90 days after the passage of health care reform legislation 64% are "very" or "somewhat" confident Medicare will be available the rest of their lives, but just 23% have the same confidence it will be here for their children. The survey further revealed that 61% of respondents are "not" confident that Medicare will be here for their children and another 14% are "unsure."
› Verified 4 days ago
| Entity Name | Mercy Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457691941 PECOS PAC ID: 7911810882 Enrollment ID: O20031112000238 |
News Archive
Humans have 25 different types of functional bitter taste receptors. These are found on our tongue, where they facilitate the taste perception of bitter tasting compounds. In addition, there are increasing findings that cells of extra-oral organs also have such receptors.
Trends indicate that survival is improving in patients with metastatic breast cancer, especially in those patients whose tumours are described as being HER2 (human epidermal growth factor receptor-2) positive, a surgical oncologist will say today (Friday 26 March) at the seventh European Breast Cancer Conference.
Pharmaceuticals, Inc. today announced interim results of a randomized, open‐label, active-control multicenter Phase 2 study of oral ridaforolimus, an investigational mTOR inhibitor, in patients with metastatic or recurrent endometrial cancer. Based on this interim analysis, the study demonstrated a statistically significant improvement in the primary endpoint of median progression-free survival (PFS) in patients receiving single-agent ridaforolimus compared to patients receiving standard-of-care treatment.
Repairing birth defects in the womb. Inserting a tiny laser into the mother's uterus to seal off an abnormal blood flow and save fetal twins. Advancing the science that may allow doctors to deliver cells or DNA to treat sickle cell anemia and other genetic diseases before birth.
A June 2010 independent survey of 408 retirees covered by Medicare revealed that 90 days after the passage of health care reform legislation 64% are "very" or "somewhat" confident Medicare will be available the rest of their lives, but just 23% have the same confidence it will be here for their children. The survey further revealed that 61% of respondents are "not" confident that Medicare will be here for their children and another 14% are "unsure."
› Verified 4 days ago
| Entity Name | Iowa Physicians Clinic Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366425274 PECOS PAC ID: 8729992318 Enrollment ID: O20031118000363 |
News Archive
Humans have 25 different types of functional bitter taste receptors. These are found on our tongue, where they facilitate the taste perception of bitter tasting compounds. In addition, there are increasing findings that cells of extra-oral organs also have such receptors.
Trends indicate that survival is improving in patients with metastatic breast cancer, especially in those patients whose tumours are described as being HER2 (human epidermal growth factor receptor-2) positive, a surgical oncologist will say today (Friday 26 March) at the seventh European Breast Cancer Conference.
Pharmaceuticals, Inc. today announced interim results of a randomized, open‐label, active-control multicenter Phase 2 study of oral ridaforolimus, an investigational mTOR inhibitor, in patients with metastatic or recurrent endometrial cancer. Based on this interim analysis, the study demonstrated a statistically significant improvement in the primary endpoint of median progression-free survival (PFS) in patients receiving single-agent ridaforolimus compared to patients receiving standard-of-care treatment.
Repairing birth defects in the womb. Inserting a tiny laser into the mother's uterus to seal off an abnormal blood flow and save fetal twins. Advancing the science that may allow doctors to deliver cells or DNA to treat sickle cell anemia and other genetic diseases before birth.
A June 2010 independent survey of 408 retirees covered by Medicare revealed that 90 days after the passage of health care reform legislation 64% are "very" or "somewhat" confident Medicare will be available the rest of their lives, but just 23% have the same confidence it will be here for their children. The survey further revealed that 61% of respondents are "not" confident that Medicare will be here for their children and another 14% are "unsure."
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ahmad Bader, MD Po Box 1475, Des Moines, IA 50305-1475 Ph: (515) 358-0100 | Dr Ahmad Bader, MD 1111 6th Ave Ste B1, Des Moines, IA 50314-2610 Ph: (515) 358-0100 |
News Archive
Humans have 25 different types of functional bitter taste receptors. These are found on our tongue, where they facilitate the taste perception of bitter tasting compounds. In addition, there are increasing findings that cells of extra-oral organs also have such receptors.
Trends indicate that survival is improving in patients with metastatic breast cancer, especially in those patients whose tumours are described as being HER2 (human epidermal growth factor receptor-2) positive, a surgical oncologist will say today (Friday 26 March) at the seventh European Breast Cancer Conference.
Pharmaceuticals, Inc. today announced interim results of a randomized, open‐label, active-control multicenter Phase 2 study of oral ridaforolimus, an investigational mTOR inhibitor, in patients with metastatic or recurrent endometrial cancer. Based on this interim analysis, the study demonstrated a statistically significant improvement in the primary endpoint of median progression-free survival (PFS) in patients receiving single-agent ridaforolimus compared to patients receiving standard-of-care treatment.
Repairing birth defects in the womb. Inserting a tiny laser into the mother's uterus to seal off an abnormal blood flow and save fetal twins. Advancing the science that may allow doctors to deliver cells or DNA to treat sickle cell anemia and other genetic diseases before birth.
A June 2010 independent survey of 408 retirees covered by Medicare revealed that 90 days after the passage of health care reform legislation 64% are "very" or "somewhat" confident Medicare will be available the rest of their lives, but just 23% have the same confidence it will be here for their children. The survey further revealed that 61% of respondents are "not" confident that Medicare will be here for their children and another 14% are "unsure."
› Verified 4 days ago
Dr. David J Boarini, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1215 Pleasant St Ste 608, Des Moines, IA 50309 Phone: 515-875-9560 Fax: 515-875-9561 | |
Zoya A. Voronovich, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1111 6th Ave Ste B1, Des Moines, IA 50314 Phone: 515-358-0100 Fax: 515-358-0109 | |
Dr. Thomas A Carlstrom, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1215 Pleasant St, Ste 608, Des Moines, IA 50309 Phone: 515-241-5760 Fax: 515-241-8161 | |
Dr. Timothy C Ryken, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1215 Pleasant St Ste 608, Des Moines, IA 50309 Phone: 515-241-5760 Fax: 515-241-8161 | |
Nicholas M Wetjen, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1215 Pleasant St Ste 608, Des Moines, IA 50309 Phone: 515-241-5760 | |
Dr. Royce W Woodroffe, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1215 Pleasant St Ste 608, Des Moines, IA 50309 Phone: 515-875-9560 Fax: 515-875-9561 | |
Dr. Joseph Edward Sherrill Ii, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1215 Pleasant St, Ste 608, Des Moines, IA 50309 Phone: 515-875-9560 Fax: 515-875-9561 |